A drug‐disease model for predicting survival in an Ebola outbreak

Abstract REGN‐EB3 (Inmazeb) is a cocktail of three human monoclonal antibodies approved for treatment of Ebola infection. This paper describes development of a mathematical model linking REGN‐EB3's inhibition of Ebola virus to survival in a non‐human primate (NHP) model, and translational scali...

Full description

Saved in:
Bibliographic Details
Main Authors: Masood Khaksar Toroghi (Author), Nidal Al‐Huniti (Author), John D. Davis (Author), A. Thomas DiCioccio (Author), Ronda Rippley (Author), Alina Baum (Author), Christos A. Kyratsous (Author), Sumathi Sivapalasingam (Author), Joel Kantrowitz (Author), Mohamed A. Kamal (Author)
Format: Book
Published: Wiley, 2022-10-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available